osmidrosis axillae
Conditions
Interventions
None listed
Sponsors
Shinanozaka Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subject who has Japanese nationality and is from 20 to less than 65 years old at the time of informed consent 2) For patients, subjects who has axillary odor score 1 or more For volunteers, subjects who has axillary odor score 0
Exclusion criteria
Exclusion criteria: 1)Subjects who has complications in axilla 2)Subjects who has any severe disease or medical history determined by investigator to be unsuitable for the study,e.g.liver, kidney,cardiac,digestive organ,circulatory organ,blood,respiratory,et cetera. 3)For volunteers, subjects who has complications or medical history of osmidrosis axillae and who has been told that axillary odor by somebody 4)Subjects who has sensitivities for alcohol 5)Subjects who have not completely disappered following symptoms within 14 days before visit;symptoms suspected or associated with COVID-19 infection such as fever, respiratory symptoms (cough, sore throat, nasal discharge, etc), malaise, taste/olfaction disorder ,etc. 6)Subjects who contacted directly with Covid-19 patients within 14 days before visit. 7)Subjects who are judged as ineligible for this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The collection amount of three substances causing odor from axillae. (3-Hydroxy-3-methylhexanoic acid(HMHA),3-Methyl-2-hexenoic acid (3M2H),3-Methyl-3-sulfanylhexan-1-ol(3M3SH) | — |
Countries
Japan
Contacts
Public ContactMichiyo Ito
Tokyo Research Center of Clinical Pharmacology Clinical Research Promotion
Outcome results
None listed